P2 receptors in cancer progression and metastatic spreading

Francesco Di Virgilio1, Simonetta Falzoni1, Anna Lisa Giuliani1

  • 1Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Italy.

Insights

The tumor microenvironment is rich in nucleosides and nucleotides. Nucleotide-selective P2 receptors on host and cancer cells can either promote anti-tumor immunity or drive tumor progression, offering therapeutic potential.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • The tumor microenvironment (TME) is characterized by high concentrations of nucleosides and nucleotides.
  • Adenosine plays a critical role in establishing an immunosuppressive TME.
  • Extracellular ATP's influence on anti-tumor immunity and host-tumor interactions requires further elucidation.

Purpose of the Study:

  • To review recent literature on the function of nucleotide-selective (P2) plasma membrane receptors in cancer.
  • To explore the dual role of P2 receptors in modulating tumor growth and anti-tumor immune responses.

Main Methods:

  • Literature review of studies investigating P2 receptor expression and function in the TME.
  • Analysis of the impact of different P2 receptor subtypes on host-tumor interactions.

Main Results:

  • P2 receptors are expressed on both host immune cells and cancer cells within the TME.
  • The specific P2 receptor subtype, inflammatory infiltrate, and tumor cell type dictate whether P2 receptor signaling promotes anti-tumor immunity or tumor progression.
  • Evidence suggests P2 receptor activity significantly influences the host-tumor crosstalk.

Conclusions:

  • Understanding the pharmacology, biochemistry, and functional roles of P2 receptors is crucial for deciphering host-tumor interactions.
  • Targeting P2 receptors presents a promising avenue for developing novel anti-cancer therapies.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Metastasis02:30

Metastasis

3.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.5K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K